PanGeo Pharma

PIL.H-X

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about PIL.H-X

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
September 22, 2003
Trading has been stopped. Plagued by a number of problems. Waiting for the company to complete its audit.
PanGeo Pharma (PIL.H-X)
September 22, 2003
Trading has been stopped. Plagued by a number of problems. Waiting for the company to complete its audit.
Robert Floyd
President, R A Floyd Management
Price
$0.290
Owned
Yes
DON'T BUY
DON'T BUY
July 22, 2003
Doesn't look good.
Doesn't look good.
David Burrows
President & Chief Investment Strategist, Barometer Capital Management
Price
$0.290
Owned
No
DON'T BUY
DON'T BUY
July 4, 2003
Auditors left and have to be replaced and trading has been stopped until their reports are in.
Auditors left and have to be replaced and trading has been stopped until their reports are in.
Robert Floyd
President, R A Floyd Management
Price
$0.290
Owned
Yes
DON'T BUY
DON'T BUY
July 2, 2003
In a very defined downtrend.
In a very defined downtrend.
Bill Carrigan
Technical Analyst, Getting Technical Info Service
Price
$0.290
Owned
No
DON'T BUY
DON'T BUY
May 30, 2003
Very extended. Squeezing their credit lines and suppliers. Have to earn $0.10 a share to support the liquidity issue.
Very extended. Squeezing their credit lines and suppliers. Have to earn $0.10 a share to support the liquidity issue.
Lou Schizas
Business Editor, Market Call
Price
$0.740
Owned
Unknown
DON'T BUY
DON'T BUY
May 6, 2003
Have had some pretty big earnings misses and management issues. May be a take over target at some point. Wait for it to drop further.
Have had some pretty big earnings misses and management issues. May be a take over target at some point. Wait for it to drop further.
Peter Hodson
CEO & Head of Research, 5i Research Inc.
Price
$0.960
Owned
Unknown
DON'T BUY
DON'T BUY
April 25, 2003
Made a good move in splitting the offices of the chairman and the CEO. They are trying to deal with their problems. Have to see an improvement before there is any interest.
PanGeo Pharma (PIL.H-X)
April 25, 2003
Made a good move in splitting the offices of the chairman and the CEO. They are trying to deal with their problems. Have to see an improvement before there is any interest.
Robert Floyd
President, R A Floyd Management
Price
$0.760
Owned
Unknown
BUY
BUY
April 10, 2003
Has warned a few times. Making some strategic moves in beefing up their management. A reasonable bet.
PanGeo Pharma (PIL.H-X)
April 10, 2003
Has warned a few times. Making some strategic moves in beefing up their management. A reasonable bet.
Robert Floyd
President, R A Floyd Management
Price
$0.770
Owned
Unknown
DON'T BUY
DON'T BUY
March 31, 2003
Likes this sector, but they just gave a lower guidance.
PanGeo Pharma (PIL.H-X)
March 31, 2003
Likes this sector, but they just gave a lower guidance.
John Sinkins, CFA
Senior Portfolio Manager, Sentry Select Capital Corp
Price
$0.690
Owned
Unknown
BUY
BUY
March 27, 2003
Earnings warnings were forcast. Seems to be corrected now. Cheap.
PanGeo Pharma (PIL.H-X)
March 27, 2003
Earnings warnings were forcast. Seems to be corrected now. Cheap.
Robert Floyd
President, R A Floyd Management
Price
$0.730
Owned
Unknown
HOLD
HOLD
March 3, 2003
Making some management changes which will take time.
Making some management changes which will take time.
Robert Floyd
President, R A Floyd Management
Price
$0.830
Owned
Unknown
PAST TOP PICK
PAST TOP PICK
February 7, 2003
(Was a top pick on Dec 18.Down 55%.) Stock was knocked down, but problems are being looked after.
PanGeo Pharma (PIL.H-X)
February 7, 2003
(Was a top pick on Dec 18.Down 55%.) Stock was knocked down, but problems are being looked after.
Robert Floyd
President, R A Floyd Management
Price
$0.920
Owned
Unknown
DON'T BUY
DON'T BUY
February 4, 2003
Way off on their earnings guidance. Will take a while to recover.
PanGeo Pharma (PIL.H-X)
February 4, 2003
Way off on their earnings guidance. Will take a while to recover.
Peter Hodson
CEO & Head of Research, 5i Research Inc.
Price
$1.010
Owned
Unknown
WEAK BUY
WEAK BUY
February 3, 2003
Could go up. Has been oversold. Treat as a trade.
PanGeo Pharma (PIL.H-X)
February 3, 2003
Could go up. Has been oversold. Treat as a trade.
Michael Smedley
Exec VP & Chief Investment Officer, Morgan Meighan & Associates
Price
$1.110
Owned
Unknown
DON'T BUY
DON'T BUY
January 31, 2003
Has missed for the 3rd time. Prefers others.
PanGeo Pharma (PIL.H-X)
January 31, 2003
Has missed for the 3rd time. Prefers others.
Andrew McCreath
Senior Portfolio Manager, Sentry Select Capital
Price
$0.930
Owned
Unknown
BUY
BUY
January 15, 2003
Starting to get into a higher margin product. Reasonable growth.
PanGeo Pharma (PIL.H-X)
January 15, 2003
Starting to get into a higher margin product. Reasonable growth.
Robert Floyd
President, R A Floyd Management
Price
$2.000
Owned
Unknown
BUY
BUY
January 14, 2003
At a good price. Growing well.
PanGeo Pharma (PIL.H-X)
January 14, 2003
At a good price. Growing well.
David Baskin
President, Baskin Wealth Management
Price
$2.020
Owned
Unknown
DON'T BUY
DON'T BUY
January 6, 2003
Great growth story. Likes the stock and management, but questions its value. A little high.
PanGeo Pharma (PIL.H-X)
January 6, 2003
Great growth story. Likes the stock and management, but questions its value. A little high.
Bruce Campbell (1)
President, Campbell and Lee InvMngmnt
Price
$2.100
Owned
Unknown
TOP PICK
TOP PICK
December 18, 2002
(Was a top pick on Nov 1. Down 6%) Made a good acquisition. Earnings are strong. Very cheap.
PanGeo Pharma (PIL.H-X)
December 18, 2002
(Was a top pick on Nov 1. Down 6%) Made a good acquisition. Earnings are strong. Very cheap.
Robert Floyd
President, R A Floyd Management
Price
$2.080
Owned
Unknown
TOP PICK
TOP PICK
November 1, 2002
Earnings are improved. Cheap.
PanGeo Pharma (PIL.H-X)
November 1, 2002
Earnings are improved. Cheap.
Robert Floyd
President, R A Floyd Management
Price
$2.230
Owned
Unknown
BUY
BUY
October 25, 2002
Doing well.
PanGeo Pharma (PIL.H-X)
October 25, 2002
Doing well.
Michael Smedley
Exec VP & Chief Investment Officer, Morgan Meighan & Associates
Price
$2.220
Owned
Unknown
DON'T BUY
DON'T BUY
September 3, 2002
In a downtrend.
PanGeo Pharma (PIL.H-X)
September 3, 2002
In a downtrend.
Larry Berman CFA, CMT, CTA
Chief Investment Officer, Partner, ETF Capital Management Inc.
Price
$2.480
Owned
Unknown
DON'T BUY
DON'T BUY
June 6, 2002
Pharmaceutical world is dangerous. Speculative.
Pharmaceutical world is dangerous. Speculative.
John Zechner
Chairman, J. Zechner & Assoc
Price
$3.190
Owned
Unknown
DON'T BUY
DON'T BUY
May 13, 2002
Has done well. Making good contracts. A little ahead of itself.
Has done well. Making good contracts. A little ahead of itself.
Bruce Campbell (1)
President, Campbell and Lee InvMngmnt
Price
$3.390
Owned
Unknown
BUY
BUY
May 8, 2002
Good growth characteristics. Has done well.
Good growth characteristics. Has done well.
Bob Boaz
Director Equ Research, Dundee Securities
Price
$3.450
Owned
Unknown
DON'T BUY
DON'T BUY
March 6, 2002
Good margins. If they can maintaim them, they'll have great growth. Wait for one or two quarters to see if the margins stay as good.
Good margins. If they can maintaim them, they'll have great growth. Wait for one or two quarters to see if the margins stay as good.
Martin Hubbes, CFA
Executive Vice-President/Chief Investment Officer, AGF Funds Inc.
Price
$3.430
Owned
Unknown
BUY
BUY
January 31, 2002
A good business and good franchises.
PanGeo Pharma (PIL.H-X)
January 31, 2002
A good business and good franchises.
Malvin Spooner
Chairman and Chief Executive Officer, Mavrix Fund Management
Price
$3.240
Owned
Unknown
DON'T BUY
DON'T BUY
January 9, 2002
Will have a hard time competing with Patheon. Expensive.
PanGeo Pharma (PIL.H-X)
January 9, 2002
Will have a hard time competing with Patheon. Expensive.
David Driscoll
President & CEO, Liberty International Investment Management Inc
Price
$3.500
Owned
Unknown
BUY
BUY
January 3, 2002
Likes very much.
PanGeo Pharma (PIL.H-X)
January 3, 2002
Likes very much.
Joe Connolly
Director of Resource and Trading, Cockfield Porretti Cunningham
Price
$3.170
Owned
Unknown
HOLD
HOLD
July 9, 2001
Moderate growth
Moderate growth
Robert Floyd
President, R A Floyd Management
Price
$1.890
Owned
Unknown
Showing 1 to 30 of 33 entries